An App-based Instructional Platform to Improve Eye Drop Recall
NCT ID: NCT06045390
Last Updated: 2025-12-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2024-09-01
2025-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Participants will be divided into two groups -- those who use the app and those who do not. The app will have narrated information regarding the drop regimen, a quiz to test understanding of the regimen, and will enable a graphical printout of the eye drops and schedule.
At one month, both groups will be assessed on their eye drop regimen recall.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
App features
1. Pictorial representation of drops (color-coded) and schedule.
2. Quiz to assess understanding of the regimen.
3. Narrated instructions (language-concordant) on how and when (frequency and eye laterality) to take each drop.
4. Graphical print-out of the regimen.
Study design
1. Study design: Randomized study, two groups: (1) patients that use the app, and (2) patients that do not use the app.
2. Study population:
Inclusion criteria: patients with primary open-angle glaucoma on at least 2 eye drops
Exclusion criteria: patients taking additional prescribed eye drops for other eye conditions; patients diagnosed within the last 3 months; patients unable to self-administer eye drops
3. Intervention: Use of an in-office app that has both graphical and verbal (language-concordant) instruction for how to use drops.
4. Main outcome measure: Ability to correctly identify drops/regimen
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
App arm
The intervention is an in-office app that contains graphical and narrated information on a patient's specific drop regimen, and includes a quiz and a graphical print-out of their drop schedule. The patient will use the app during their clinic visit.
App
App features (App will be used during the office visit):
* Pictorial representation of drops (color-coded) and schedule.
* Quiz to assess understanding of the regimen.
* Narrated instructions (language-concordant) on how and when (frequency and eye laterality) to take each drop.
* Graphical print-out of the regimen.
Standard arm
The standard arm will be the standard of care, which involves a provider explanation of their drop regimen (using a phone interpreter if needed).
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
App
App features (App will be used during the office visit):
* Pictorial representation of drops (color-coded) and schedule.
* Quiz to assess understanding of the regimen.
* Narrated instructions (language-concordant) on how and when (frequency and eye laterality) to take each drop.
* Graphical print-out of the regimen.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* drop regimen of at least 2 pressure-lowering drops
* languages supported at this time: English, Spanish, Cantonese
Exclusion Criteria
* inability to self-administer eye drops
* inability to engage with app (either visual or other barrier)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, San Francisco
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Frank Brodie, MD
Role: PRINCIPAL_INVESTIGATOR
UCSF, Department of Ophthalmology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
San Francisco General Hospital
San Francisco, California, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Newman-Casey PA, Blachley T, Lee PP, Heisler M, Farris KB, Stein JD. Patterns of Glaucoma Medication Adherence over Four Years of Follow-Up. Ophthalmology. 2015 Oct;122(10):2010-21. doi: 10.1016/j.ophtha.2015.06.039. Epub 2015 Aug 25.
Zolnierek KB, Dimatteo MR. Physician communication and patient adherence to treatment: a meta-analysis. Med Care. 2009 Aug;47(8):826-34. doi: 10.1097/MLR.0b013e31819a5acc.
Newman-Casey PA, Robin AL, Blachley T, Farris K, Heisler M, Resnicow K, Lee PP. The Most Common Barriers to Glaucoma Medication Adherence: A Cross-Sectional Survey. Ophthalmology. 2015 Jul;122(7):1308-16. doi: 10.1016/j.ophtha.2015.03.026. Epub 2015 Apr 24.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
23-39908
Identifier Type: -
Identifier Source: org_study_id